NDC 71656-021-30 - POTASSIUM CHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71656-021
- Requested NDC
- 71656-021-30
- Package NDCs from labels
- 71656-021-16, 71656-021-15, 71656-021-50, 71656-021-01, 71656-021-30, 71656-021-51, 71656-021-02
- Manufacturer
- American Health Packaging
- Effective date
- 2026-09-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE - American Health Packaging | American Health Packaging | 2026-09-23 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Saptalis Pharmaceuticals, LLC | Saptalis Pharmaceuticals, LLC | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-08-24 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-15 | POTASSIUM CHLORIDE | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 71656-021-16 | POTASSIUM CHLORIDE | 473 mL in 1 BOTTLE | SOLUTION | 473 | 5 | |
| 71656-021-30 | POTASSIUM CHLORIDE | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71656-021-01 | ML - Milliliter | 71656-021 | 6bd0ebbf-a7a4-40f2-b463-9f94ddbce7be | 1 | 2024-06-10 |
| 71656-021-15 | ML - Milliliter | 71656-021 | c27304b6-be2d-4797-aac3-a530ab28e3ba | 1 | 2024-06-10 |
| 71656-021-16 | ML - Milliliter | 71656-021 | 99d9cda5-bc17-4912-b16e-3b4dd995bd14 | 1 | 2024-08-12 |
| 71656-021-30 | ML - Milliliter | 71656-021 | 0b65870e-cf13-427b-af5f-c812d5eb9e9c | 1 | 2025-05-14 |
| 71656-021-50 | ML - Milliliter | 71656-021 | b55652f8-ada5-4d3a-a114-b9e2fbac018c | 1 | 2023-12-05 |
| 71656-021-51 | ML - Milliliter | 71656-021 | 5d529fbd-3765-4e17-9818-571896c812e3 | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Schuessler Tissue Salts Kali Mur Glandular Tonic 5 | KALI MURIATICUM | Martin & Pleasance Pty Ltd | f4e2df47-0c8f-48c5-b6f3-2bd1e68afb89 | 2025-07-18 | Warnings | 660YQ98I10 |
| Potassium chloride | POTASSIUM CHLORIDE | Camber Pharmaceuticals, Inc. | fb2f6e74-4c1f-40c5-88a1-b88c069d4c75 | 2025-07-17 | Warnings, Adverse reactions | 314182 312515 660YQ98I10 |
| SilkTears | GLYCERIN OPHTHALMIC SOLUTION | SilkTears | 3866e2c1-051b-0b01-e063-6394a90af5cf | 2025-07-16 | Warnings | PDC6A3C0OX |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | XF417D3PSL |
| potassium chloride | POTASSIUM CHLORIDE | Solco Healthcare LLC | 52d91d76-8c7f-40f1-9f5c-e05962cabedd | 2025-07-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 616f0de7-8843-44a1-8fa6-274d889286aa | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 1ff53330-065c-4213-9c0c-ac498621d09d | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | e61a4522-b91d-400a-952c-6f035e4610dd | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON M | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | b89910f6-4ff5-4a62-8269-696f7c10e4f6 | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Nikzon Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, AND PRAMOXINE HYDROCHLORIDE | Genomma Lab USA | 8f9a9939-2c99-489f-b597-9a51ec2684f9 | 2025-07-14 | Warnings | PDC6A3C0OX |
| Endocrinpath | ALFALFA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, FUCUS VESICULOSUS, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, PANCREAS SUIS, PHYTOLACCA DECANDRA, PITUITARUM POSTERIUM (BOVINE), SARSAPARILLA (SMILAX REGELII), SILICEA, SYZYGIUM JAMBOLANUM, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corporation | 70f84941-b8a1-48f4-9c05-554e554f0049 | 2025-07-11 | Warnings | XF417D3PSL |
| POTASSIUM CHLORIDE IN SODIUM CHLORIDE | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | ecc38772-246a-46c4-b42a-b9b81124f27f | 2025-07-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Upsher-SmithLaboratories, LLC | ad584ce4-a64d-4851-80e9-0eeedc0b9d06 | 2025-07-10 | Warnings, Adverse reactions | 660YQ98I10 |
| Maximum Strength Hemorrhoidal Cream with Aloe | GLYCERIN, PHENYLEPHINE HCI, PRAMOXINE HCI, PETROLATUM | Chain Drug Marketing Association | 396ea654-8be1-591a-e063-6294a90a11e2 | 2025-07-08 | Warnings | PDC6A3C0OX |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Belleview Biosciences LLC | 3245e0e5-5e7f-c3f7-e063-6394a90ac258 | 2025-07-07 | Adverse reactions | XF417D3PSL |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 38cf4e43-280b-eb96-e063-6294a90a5949 | 2025-07-02 | Warnings | PDC6A3C0OX |
| SEFUDUN FUNGAL NAIL PATCHES | GLYCERIN | Shenzhen Shandian Jingling Technology Co., Ltd. | 38db97d6-27c8-da99-e063-6294a90aac66 | 2025-07-01 | Warnings | PDC6A3C0OX |
| Schuessler Tissue Salts Kali Mur Glandular Tonic 5 | KALI MURIATICUM | Martin & Pleasance Pty Ltd | 4b2d8d03-c829-4292-ad94-993376d81b8f | 2025-07-01 | Warnings | 660YQ98I10 |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | B22547B95K |
| Nauzene Chewables Ginger Honey | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | 25c9825d-a4e8-4671-e063-6294a90ab46d | 2025-06-24 | Warnings | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.